MYC and neoplasm: Importantly, in this scenario, GSK-3 inhibition prevented the phosphorylation of its substrates c-Myc and β-catenin, and consequently promoted their upregulation, which led to c-Myc- and β-catenin-dependent tumor suppression [24].